• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    hENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Hent1.pdf
    Size:
    1.794Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Aughton, K.
    Elander, N. O.
    Evans, A.
    Jackson, R.
    Campbell, F.
    Costello, E.
    Halloran, C. M.
    Mackey, J. R.
    Scarfe, A. G.
    Valle, Juan W
    Carter, R.
    Cunningham, D.
    Tebbutt, N. C.
    Goldstein, D.
    Shannon, J.
    Glimelius, B.
    Hackert, T.
    Charnley, R. M.
    Anthoney, A.
    Lerch, M. M.
    Mayerle, J.
    Palmer, D. H.
    Buchler, M. W.
    Ghaneh, P.
    Neoptolemos, J. P.
    Greenhalf, W.
    Show allShow less
    Affiliation
    Liverpool Experimental Cancer Medicine Centre, 2nd Floor Sherrington Building, Ashton St, University of Liverpool, Liverpool L69 3GE, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Citation
    Aughton K, Elander NO, Evans A, Jackson R, Campbell F, Costello E, et al. hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA Vol. 13, Cancers. MDPI AG; 2021. p. 5758.
    Journal
    Cancers
    URI
    http://hdl.handle.net/10541/624966
    DOI
    10.3390/cancers13225758
    PubMed ID
    34830914
    Type
    Article
    ae974a485f413a2113503eed53cd6c53
    10.3390/cancers13225758
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.
    • Authors: Elander NO, Aughton K, Ghaneh P, Neoptolemos JP, Palmer DH, Cox TF, Campbell F, Costello E, Halloran CM, Mackey JR, Scarfe AG, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Shannon J, Dervenis C, Glimelius B, Deakin M, Charnley RM, Anthoney A, Lerch MM, Mayerle J, Oláh A, Büchler MW, Greenhalf W, European Study Group for Pancreatic Cancer
    • Issue date: 2018 Apr
    • Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
    • Authors: Farrell JJ, Elsaleh H, Garcia M, Lai R, Ammar A, Regine WF, Abrams R, Benson AB, Macdonald J, Cass CE, Dicker AP, Mackey JR
    • Issue date: 2009 Jan
    • Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial.
    • Authors: Shin DW, Lee JC, Kim J, Yoon YS, Han HS, Kim H, Hwang JH
    • Issue date: 2021 Jun
    • Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy.
    • Authors: Okamura Y, Yasukawa S, Narimatsu H, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Yamakita K, Takahashi A, Kainuma O, Hishinuma S, Yamaguchi R, Nagino M, Hirano S, Yanagisawa A, Mori K, Uesaka K
    • Issue date: 2020 Feb
    • A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.
    • Authors: Kalloger SE, Riazy M, Tessier-Cloutier B, Karasinska JM, Gao D, Peixoto RD, Samimi S, Chow C, Wong HL, Mackey JR, Renouf DJ, Schaeffer DF
    • Issue date: 2017 Jul
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.